Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Thorax
|
September 4, 2025
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation
Idan Bokobza, Melanie Le Sayec, Cara Bossley, et al.
Health Technology Assessment (Winchester, England)
|
February 28, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)
M J Crawford, H Killaspy, T R Barnes, et al.
The European Respiratory Journal
|
September 1, 2009
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A Scherpereel, P Astoul, P Baas, et al.
ERJ Open Research
|
February 12, 2021
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia
Rebecca F D'Cruz, Michael D Waller, Felicity Perrin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals
E De Wachter, K De Boeck, I Sermet-Gaudelus, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 20, 2024
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders
N J Simmonds, K W Southern, E De Wachter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis
Kevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Leukemia
|
June 17, 2017
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
S K Kumar, M A Dimopoulos, E Kastritis, et al.
Frontiers in Immunology
|
January 5, 2023
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies
Natasha Kekre, Kevin A Hay, John R Webb, et al.
The Lancet. Respiratory Medicine
|
July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Thorax
|
September 4, 2025
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation
Idan Bokobza, Melanie Le Sayec, Cara Bossley, et al.
Health Technology Assessment (Winchester, England)
|
February 28, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)
M J Crawford, H Killaspy, T R Barnes, et al.
The European Respiratory Journal
|
September 1, 2009
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A Scherpereel, P Astoul, P Baas, et al.
ERJ Open Research
|
February 12, 2021
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia
Rebecca F D'Cruz, Michael D Waller, Felicity Perrin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals
E De Wachter, K De Boeck, I Sermet-Gaudelus, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 20, 2024
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders
N J Simmonds, K W Southern, E De Wachter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis
Kevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Leukemia
|
June 17, 2017
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
S K Kumar, M A Dimopoulos, E Kastritis, et al.
Frontiers in Immunology
|
January 5, 2023
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies
Natasha Kekre, Kevin A Hay, John R Webb, et al.
The Lancet. Respiratory Medicine
|
July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Page
of 19